Microalbuminuria in relation to the metabolic syndrome and its components in a Chinese population

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  Sheng, Chang Sheng ^a   Hu, Bang Chuan ^a   Fan, Wang Xiang ^a   Zou, Jun ^a   Li, Yan ^a   Wang, Ji Guang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ANTHROPOMETRY; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; PRIORITY JOURNAL; SMOKING; SUBURBAN AREA; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URINALYSIS; WAIST CIRCUMFERENCE;

EID: 79953688571     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-6     Document Type: Article

References (21)

1. Update on microalbuminuria as a biomarker in renal and cardiovascular disease. HJ Lambers Heerspink JW Brinkman SJ Bakker RT Gansevoort D de Zeeuw, Curr Opin Nephrol Hypertens 2006 15 631 6 10.1097/01.mnh.0000247496.54882.3f 17053479 (Pubitemid 44607436)
2. Microalbuminuria and endothelial dysfunction: emerging targets for primary prevention of end-organ damage. P Ochodnicky RH Henning RP van Dokkum D de Zeeuw, J Cardiovasc Pharmacol 2006 47 Suppl 2 151 62 10.1097/00005344- 200606001-00009 16794452
3. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. HC Gerstein JF Mann Q Yi B Zinman SF Dinneen B Hoogwerf JP Hallé J Young A Rashkow C Joyce S Nawaz S Yusuf HOPE Study Investigators, JAMA 2001 286 421 6 10.1001/jama.286.4.421 11466120 (Pubitemid 32681484)
4. Prevalence of albuminuria and cardiovascular risk profile in a referred cohort of patients with type 2 diabetes: an Asian perspective. CY Pan LT Ho S Soegondo W Prodjosudjadi S Suwanwalaikorn SC Lim TM Chan KW Chow M Thoenes DS Choi DEMAND Study Investigators, Diabetes Technol Ther 2008 10 397 403 10.1089/dia.2007.0296 18715217
5. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. KG Alberti PZ Zimmet, Diabet Med 1998 15 539 53 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693 (Pubitemid 28319935)
6. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. National Cholesterol Education Program (NCEP), Circulation 2002 106 3143 421 12485966
7. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr JA Spertus F Costa, Circulation 2005 112 2735 52 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
8. International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. KG Alberti RH Eckel SM Grundy PZ Zimmet JI Cleeman KA Donato JC Fruchart WP James CM Loria SC Smith Jr, Circulation 2009 120 1640 5 10.1161/CIRCULATIONAHA. 109.192644 19805654
9. The metabolic syndrome. RH Eckel KG Alberti SM Grundy PZ Zimmet, Lancet 2010 375 181 3 10.1016/S0140-6736(09)61794-3 20109902
10. Association between microalbuminuria and the metabolic syndrome: NHANES III. L Palaniappan M Carnethon SP Fortmann, Am J Hypertens 2003 16 952 8 10.1016/S0895-7061(03)01009-4 14573334 (Pubitemid 37315495)
11. Relationship between the prevalence of microalbuminuria and components of metabolic syndrome in Shanghai. Q Li WP Jia JQ Lu L Chen YM Wu SY Jiang KS Xiang, Chin J Epidemiol 2004 25 65 88 in Chinese
12. The association between microalbuminuria and metabolic syndrome in the general population in Japan: the Takahata study. Z Hao T Konta S Takasaki H Abiko M Ishikawa T Takahashi A Ikeda K Ichikawa S Kawata T Kato I Kubota, Intern Med 2007 46 341 6 10.2169/internalmedicine.46.6056 17409594 (Pubitemid 46585471)
13. Microalbuminuria and the metabolic syndrome and its component s in the Chinese population. CC Lin CS Liu TC Li CC Chen CI Li WY Lin, Eur J Clin Invest 2007 37 783 90 10.1111/j.1365-2362.2007.01865.x 17888089
14. The prevalence of microalbuminuria and its relationships with the components of metabolic syndrome in the general population of China. BD Chen DG Yang Y Chen WY Xu B Ye ZY Ni, Chin Chim Acta 2010 411 705 9
15. Microalbuminuria as an early marker for cardiovascular disease. D de Zeeuw HH Parving RH Henning, J Am Soc Nephrol 2006 17 2100 5 10.1681/ASN.2006050517 16825327 (Pubitemid 44141898)
16. Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus. BI Levy EL Schiffrin JJ Mourad D Agostini E Vicaut ME Safar HA Struijker-Boudier, Circulation 2008 118 968 76 10.1161/CIRCULATIONAHA. 107.763730 18725503
17. First morning voids are more reliable than spot urine samples to assess microalbuminuria. EC Witte HJ Lambers Heerspink D de Zeeuw SJ Bakker PE de Jong R Gansevoort, J Am Soc Nephrol 2009 20 436 43 10.1681/ASN.2008030292 19092125
18. Definition of microalbuminuria in first-morning and random spot urine in diabetic patients. T Babazono C Takahashi Y Iwamoto, Diabetes Care 2004 27 1838 9 10.2337/diacare.27.7.1838 15220278 (Pubitemid 38857475)
19. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. RK Simmons KG Alberti EA Gale S Colagiuri J Tuomilehto Q Qiao A Ramachandran N Tajima I Brajkovich Mirchov A Ben-Nakhi G Reaven B Hama Sambo S Mendis G Roglic, Diabetologia 2010 53 600 5 10.1007/s00125-009-1620-4 20012011
20. Racial/ethnic differences in microalbuminuria among adults with prehypertension and hypertension: National Health and Nutrition Examination Survey (NHANES), 1999-2006. MO Ogunniyi JB Croft KJ Greenlund WH Giles GA Mensah, Am J Hypertens 2010 23 859 64 10.1038/ajh.2010.77 20414192
21. Impact of non-alcoholic fatty liver disease on microalbuminuria in patients with prediabetes and diabetes. ST Hwang YK Cho JW Yun JH Park HJ Kim DI Park CI Sohn WK Jeon BI Kim EJ Rhee KW Oh WY Lee W Jin, Intern Med J 2010 40 437 42 10.1111/j.1445-5994.2009.01979.x 19460054